ainewsblitz.com

Breaking

AstraZeneca CFO Says AI Is Accelerating Drug Development as Cancer Medicines Drive Profit Growth

AstraZeneca CFO Says AI Is Accelerating Drug Development as Cancer Medicines Drive Profit Growth
  • Healthcare
  • AI Agents
  • Sales & Business

AstraZeneca Chief Financial Officer Aradhana Sarin said artificial intelligence is transforming how the pharmaceutical company discovers and develops medicines, helping bring treatments to patients faster, as the drugmaker reported that its cancer portfolio spurred profit growth.

Continue reading

The rest of this article is for AI News Blitz readers. Choose an option below to keep reading.

$20
Read this article
$29/month
Unlimited — all 27,934 articles, the full archive, and comprehension quizzes
Save 72%
$98/year
≈ $8.17/month
Unlimited, billed once a year